Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-nucleus transcriptomics identifies SPON1 as a candidate mediator of the anti-fibrotic effect of <i>Abelmoschus manihot</i> (L.) in diabetic kidney disease.

American journal of translational research·2026
Same author

Comparison of anesthesia efficacy between subclavius muscle plane block and interscalene brachial plexus block for open reduction and internal fixation of clavicle fractures: study protocol for a randomized non-inferiority clinical trial.

Trials·2026
Same author

Low serum dehydroepiandrosterone sulfate is related to diabetic retinopathy in males with type 2 diabetes mellitus.

Journal of translational medicine·2026
Same author

IntentionAR: An Intention-Driven Camera-Projector System for AR Assembly Guidance.

IEEE transactions on visualization and computer graphics·2026
Same author

From Black Box to Biological Insight: AttentioFuse Unlocks Multi-Omics Dynamics in Lung Cancer.

Cancers·2026
Same author

Study on the effects of spraying nanomaterial-encapsulated dsRNA targeting the trehalose-6-phosphate synthase gene on the growth and reproduction of Nilaparvata lugens.

Pesticide biochemistry and physiology·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Ensemble Machine Learning Predicts Platinum Resistance in Ovarian Cancer Using Laboratory Data.

Xueting Peng1, Yangyang Zhang2, Chaoyu Zhu3

  • 1Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.

Cancers
|May 4, 2026
PubMed
Summary
This summary is machine-generated.

A new machine learning model uses routine lab data to predict platinum resistance in ovarian cancer. This tool helps rule out resistance, guiding treatment decisions and improving patient care.

Keywords:
ensemble learningmachine learningneoadjuvant chemotherapyovarian cancerplatinum resistancepredictive modelroutine laboratory data

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.8K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

5.8K

Related Experiment Videos

Last Updated: May 5, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.8K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

5.8K

Area of Science:

  • Oncology
  • Biostatistics
  • Machine Learning

Background:

  • Platinum resistance is a major challenge in ovarian cancer treatment.
  • Current predictive markers are often retrospective or costly.
  • There's a need for accessible pre-treatment tools to predict treatment response.

Purpose of the Study:

  • To develop a machine learning model for predicting platinum resistance in ovarian cancer.
  • To create a dynamic weighted fusion (DWF) model using routine laboratory data.
  • To provide bidirectional risk stratification, especially ruling out resistance before treatment.

Main Methods:

  • Retrospective analysis of 70 baseline clinical features from 2019-2023.
  • Development of a DWF framework integrating 168 algorithms.
  • Evaluation using AUC, accuracy, sensitivity, and specificity, with oversampling for class imbalance.

Main Results:

  • The DWF model achieved an AUC of 0.760, outperforming individual classifiers.
  • Consistent performance across different initial treatment strategies was observed.
  • Feature interpretation indicated resistance is linked to inflammation and hypercoagulability.

Conclusions:

  • The DWF model effectively stratifies ovarian cancer patients based on platinum resistance risk.
  • It offers confidence in proceeding with standard therapies for low-risk patients.
  • High-risk alerts enable early intervention and enhanced surveillance.